• Sulforaphane, Oxidative Stress, and NLRP3 in Colitis

  2026-10-07

  A 2024 study in Biomedicine & Pharmacotherapy examined how sulforaphane affects oxidative stress and NLRP3 inflammasome activity in a mouse model of ulcerative colitis. The findings support a redox-linked anti-inflammatory mechanism, while remaining preclinical and insufficient to establish sulforaphane as a selective NLRP3 inhibitor or clinical treatment.

• Vernakalant for Rapid Conversion of Atrial Fibrillation

  2026-10-07

  A phase 3 randomized trial found that vernakalant converted recent-onset atrial fibrillation to sinus rhythm substantially more often and more rapidly than placebo. The study’s main contribution was clinical validation of an atrial-focused ion-channel strategy, while its placebo-controlled design leaves important questions about comparison with electrical cardioversion, other antiarrhythmics, and longer-term outcomes.

• MMV Pandemic Response Box: Antimicrobial Screening

  2026-10-06

  Sivasankar and colleagues evaluated compounds from the MMV Pandemic Response Box against clinically relevant multidrug-resistant bacterial and fungal isolates, combining broad primary screening with persister and fungicidal assessments. The study identifies several candidates with activity against resistant Acinetobacter baumannii, Pseudomonas aeruginosa, Candida auris, Candida albicans, and Aspergillus niger, while showing why in vitro hits require target, safety, pharmacology, and clinical validation.

• Dutasteride in Translational Prostate Research

  2026-10-06

  Dutasteride is a dual 5-alpha-reductase inhibitor used in research to examine androgen metabolism, testosterone-to-DHT conversion, prostate cancer biology, and BPH-related mechanisms. Available evidence supports a plausible mechanistic role, but supplier-reported cellular and animal findings should not be treated as equivalent to independently validated clinical evidence.

• Catalpol in Cancer: Mechanisms, Evidence, and Limits

  2026-10-05

  This 2025 review synthesizes preclinical evidence that catalpol may influence cancer cell survival, inflammation, metastasis, and treatment response across several tumor types. Its main contribution is a mechanism-centered map of findings, while the absence of clinical trials means that therapeutic relevance remains provisional and requires better translational validation.

• SERCA-ER Stress and Hematopoietic Stem Cell Mobilization

  2026-10-05

  Li et al. identify SERCA-mediated endoplasmic reticulum stress as a regulator of hematopoietic stem cell mobilization, linking SERCA inhibition to the CaMKII–STAT3–CXCR4 axis. The findings support a mechanistic model in which reduced CXCR4 surface expression helps release stem and progenitor cells from bone marrow, while also highlighting important limits before translation to human transplantation.

• Sulfamonomethoxine: From Folate Biology to Ecological Risk

  2026-10-03

  Sulfamonomethoxine is examined here through a cross-trophic evidence framework linking folate-pathway activity with aquatic toxicity. The analysis clarifies what the key five-organism study demonstrates, where its findings apply, and how fate data should—and should not—be interpreted.

• Hexetidine Mouthwash: A Systematic Review

  2026-10-02

  This systematic review evaluated hexetidine mouthwash as a monotherapy or adjunct for controlling dental plaque and gingival inflammation. By narrowing 168 records to six eligible publications, it concluded that hexetidine offered less favorable overall value than chlorhexidine when observed benefits were considered alongside side effects.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-10-01

  Use a Cap1-structured, 5-moUTP-modified reporter to compare mRNA delivery, translation, and cell compatibility with a clear fluorescent endpoint. This workflow also shows how the transcript can support peptide-nanotube formulation studies and carefully controlled in vivo imaging experiments.

• Angiotensin I: Practical Assay Workflows

  2026-10-01

  Build more reproducible renin–angiotensin system experiments with Angiotensin I as a controlled precursor for ACE-conversion, pathway, and drug-screening studies. This guide combines peptide-handling guidance with a cautious, data-informed translation of spectral preprocessing methods for complex assay matrices.

• Meropenem trihydrate in Resistance Research

  2026-09-30

  Meropenem trihydrate supports controlled antibacterial challenges, resistance phenotyping, and metabolomics workflows that connect observable growth behavior with molecular signatures. This guide translates recent LC-MS/MS findings into practical assay design, sample-handling choices, and troubleshooting strategies for antibiotic resistance studies and infection models.

• Brassinolide Beyond the Product Page

  2026-09-30

  Brassinolide, also known as 24-Epibrassinolide, is more than a plant growth regulator. Its plant bioassay profile, PC-3 apoptosis data, and diabetic-rat findings create a useful translational framework—provided researchers distinguish assay-specific activity from cross-domain therapeutic promise.

• PPARγ, Macrophage Polarization, and DSS-Induced IBD

  2026-09-29

  This study identifies PPARγ activation as a regulator of macrophage polarization and intestinal injury in a dextran sulfate sodium model of inflammatory bowel disease. Its central contribution is linking reduced STAT-1 signaling and enhanced STAT-6 signaling with improved inflammatory symptoms, mucosal architecture, and barrier-associated protein expression.

• Live Imaging Reveals Mitotic Errors in Human Embryos

  2026-09-29

  Abdelbaki et al. combine blastocyst-stage mRNA electroporation, light-sheet microscopy, and deep-learning segmentation to observe chromosome segregation in living human embryos near implantation. The study documents de novo multipolar divisions, lagging chromosomes, misalignment, and mitotic slippage, while tracking suggests that many lagging chromosomes are passively inherited; the workflow also clarifies what fluorescent mRNA controls can and cannot establish in related mammalian-cell assays.

• Tomivosertib: MNK1 Inhibitor Workflows

  2026-09-28

  Tomivosertib links target-proximal MNK1/2 inhibition to rapid eIF4E Ser209 dephosphorylation, making it useful for neuronal electrophysiology, cancer-cell assays, and metabolic studies. This workflow-focused guide translates the human DRG reference study into practical dose selection, assay design, and troubleshooting steps.

8149 records 1/544 page Next 12345 下5页 Last page